SCM
ZBH icon

Shapiro Capital Management’s Zimmer Biomet ZBH Stock Holding History

Shapiro Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.1M Sell
605,411
-46,553
-7% -$4.08M 3.16% 15
2026
Q1 		$59M Buy
651,964
+90,330
+16% +$8.29M 3.68% 9
2025
Q4 		$50.5M Sell
561,634
-203,854
-27% -$19.3M 2.67% 19
2025
Q3 		$75.4M Buy
765,488
+15,600
+2% +$1.55M 3.27% 11
2025
Q2 		$68.4M Sell
749,888
-107,868
-13% -$10.4M 3% 16
2025
Q1 		$97.1M Sell
857,756
-87,371
-9% -$9.35M 4% 7
2024
Q4 		$99.8M Sell
945,127
-55,133
-6% -$5.92M 3.39% 9
2024
Q3 		$108M Sell
1,000,260
-28,101
-3% -$3.07M 3.37% 15
2024
Q2 		$112M Buy
1,028,361
+106,855
+12% +$12.6M 3.38% 11
2024
Q1 		$122M Sell
921,506
-71,034
-7% -$8.87M 3.27% 12
2023
Q4 		$121M Buy
+992,540
New +$111M 3.34% 13

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Shapiro Capital Management's ZBH Position: Q2 2026 in Review

Shapiro Capital Management reduced its Zimmer Biomet (ZBH) stake by 7.1% in Q2 2026, selling an estimated $4.08M and leaving 605,411 shares worth $52.1M. The position accounts for 3.16% of the portfolio, ranked #15.

Shapiro Capital Management first reported a position in ZBH in Q4 2023 and has held it in 11 quarters since. The position peaked at $122M in Q1 2024. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Shapiro Capital Management held 605,411 shares of Zimmer Biomet worth $52.1M as of Q2 2026.
  • Shapiro Capital Management sold 46,553 Zimmer Biomet shares in Q2 2026, an estimated $4.08M.
  • Zimmer Biomet made up 3.16% of Shapiro Capital Management's portfolio in Q2 2026, its #15 holding.
  • Shapiro Capital Management first reported a position in Zimmer Biomet in Q4 2023 and has held it in 11 quarters since.
  • Shapiro Capital Management's Zimmer Biomet position peaked at $122M in Q1 2024.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Shapiro Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.